[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015 Strategies in the Spanish Hospital Hemostasis Diagnostic Testing Market

February 2015 | 390 pages | ID: 20E26CD7EC1EN
Venture Planning Group

US$ 3,120.00 US$ 3,900.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new report from VPGMarketResearch contains 390 pages, 28 tables, and presents a comprehensive analysis of the Spanish hospital hemostasis diagnostic testing market, including:
  • Major issues pertaining to the Spanish coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • Volume and sales forecasts for 40 coagulation procedures performed in Spanish hospitals, including typical coagulation daily work loads.
  • Review of current instrumentation technologies, and a feature comparison of leading analyzers.
  • Reagent and instrument sales forecasts.
  • Sales and market shares of leading reagent and instrument suppliers.
  • Review of coagulation technologies and their potential market applications.
  • Major opportunities for coagulation instruments and consumables.
  • Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for instrument and reagent suppliers.
Contains 390 pages and 28 tables
Worldwide Market and Technology Overview

A. Major Routine and Special Coagulation Tests

1. INTRODUCTION
2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
3. ALPHA-2 ANTIPLASMIN
4. ANTITHROMBIN III
5. BLEEDING TIME
6. D-DIMER
7. ETHANOL FLOCCULATION TEST
8. EUGLOBULIN LYSIS
9. FACTOR ASSAYS
  a. Introduction
  b. Factor II
  c. Factor V/Factor V Leiden
  d. Factor VII
  e. Factor VIII
  f. Factor IX
  g. Factor IXa
  h. Factor X (Stuart Factor)
  i. Factor Xa
  j. Factor XI
  k. Factor XII
  l. Factor XIII
10. FIBRIN DEGRADATION PRODUCTS
11. FIBRINOGEN
12. HEPARIN
13. HIRUDIN
14. HYPERCOAGULABILITY AND THROMBOSIS
15. LIPOPROTEIN A
16. PLASMIN
17. PLASMINOGEN
18. PLASMINOGEN ACTIVATOR INHIBITOR (PAI)
19. PLATELET FUNCTION TESTS
20. PLATELET AGGREGATION
21. PROTEINS C AND S
22. PROTHROMBIN FRAGMENT 1.2
23. PROTHROMBIN TIME (PT)
24. REPTILASE TIME
25. THROMBIN TIME
26. TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA)
27. VON WILLEBRAND'S FACTOR

B. Instrumentation Review

Introduction
Benk Hemolab
Benk TRT Thrombotimer
Bio/Data MCA
Bio/Data MCA
Bio/Data PAP-4C D/4D/4C
Cardiovascular Diagnostics COAG
Diagnostica Stago STA Compact
Diagnostica Stago STA-R
Diagnostica Stago Star 4/8
Helena Laboratories Cascade
Helena Laboratories Cascade M
Helena Laboratories PACKS-4
Helena THOR
Instrumentation Laboratory ACL 100 and 1000 series
Instrumentation Laboratory ACL6000
Instrumentation Laboratory ACL7000
Instrumentation Laboratory ACL9000
Instrumentation Laboratory Electra 1000C
Instrumentation Laboratory Electra 1400C
Instrumentation Laboratory Electra 1600/C
Instrumentation Laboratory Electra 1800C
Instrumentation Laboratory Futura
ITC Hemochron 8000
Roche Diagnostics CoaguChek
Siemens BCS
Siemens BCT
Siemens BF II/Fibrintimer Series
Sysmex CA-50
Sysmex CA-500
Sysmex CA-1500
Sysmex CA-5000/CA-1000
Sysmex CA-6000
Sysmex CA-7000
Teco Coatron II/Jr./AccuStasis 5000
Trinity Biotech Amax CS190
Trinity Biotech Amax CS400
Trinity Biotech Coag-A-Mate Max
Trinity Biotech KC 40, 4A, 1A Series
Trinity Biotech MDA
Trinity Biotech Coag-A-Mate MTX
Trinity Biotech Coag-A-Mate RA4
Trinity Biotech Coag-A-Mate XC/Plus
Trinity Biotech Coag-A-Mate XM

C. Major in Vitro Diagnostic Technologies and Their Potential Applications

1. CHROMOGENIC SUBSTRATES
2. MONOCLONAL AND POLYCLONAL ANTIBODIES
3. IMMUNOASSAYS
  a. Applications
  b. Technological Principle
  c. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    EMIT
    Dot Immunobinding Assays
    Capillary Immunoassays
    Enzyme Amplification
    Electrochemical Immunoassay
  d. Fluorescent Immunoassays
    Fluorescence Polarization
    Time-Resolved Pulse Fluorescence
    Fluorescence Lifetime
  e. Latex Agglutination
  f. Immunoprecipitation
4. MICROCOMPUTERS
5. AUTOMATION
6. ROBOTICS
7. DNA PROBES
  a. Overview
  b. Amplification Methods
    PCR
    Ligase Chain Reaction
    Branched DNA
    Q-Beta Replicase
    NASBA
    SDA
    3 SR
    HPA
    Two-Tiered System
    LAT
8. ARTIFICIAL INTELLIGENCE
9. DRY CHEMISTRY
10. BIOSENSORS

D. Worldwide Market Overview

1. BUSINESS ENVIRONMENT
2. MARKET STRUCTURE
3. MARKET SIZE AND GROWTH
4. POC TESTING MARKET

Spain

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES


DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS


ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
American Diagnostica
Avocet Medical
Axis-Shield
Beckman Coulter
Becton Dickinson
Bio/Data Corporation
Biosite
Chrono-Log
Corgenix Medical
Diagnostica Stago
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Nanogen
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
Trinity Biotech
ZyCare

LIST OF TABLES

Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Executive Summary Table:Spain, Hospital Coagulation Diagnostics Market By Product Category
Spain, Hospital Laboratories Performing Coagulation Tests By Bed Size
Spain, Hospital Laboratories Average Daily Test Volume
Spain, Hospital Laboratories Coagulation Test Volume by Assay
Spain, Major Suppliers of Coagulation Reagents, Estimated Sales and Market Shares
Spain, Major Suppliers of Coagulation Analyzers, Estimated Sales and Market Shares
Spain, Total Coagulation Diagnostics Market By Product Category
Spain, Major Suppliers of Coagulation Diagnostic Products, Estimates Sales and Market Shares


More Publications